{"entity":{"id":"lungenclinic-grosshansdorf","kind":"institution","name":"LungenClinic Grosshansdorf","aka":["Lung Clinic Grosshansdorf","Airway Research Center North (ARCN)"],"tldr":"Specialist lung hospital near Hamburg whose thoracic oncology department, under Martin Reck, has led many of the pivotal immunotherapy trials in lung cancer, including KEYNOTE-024.","summary":"LungenClinic Grosshansdorf is a specialist hospital for lung disease outside Hamburg and a site of the German Center for Lung Research (Airway Research Center North). Its Department of Thoracic Oncology, headed by Martin Reck, was the lead centre for KEYNOTE-024, the 2016 trial that established first-line pembrolizumab for PD-L1-high non-small-cell lung cancer, and has contributed to most large lung cancer immunotherapy and small-cell lung cancer trials since.","asOf":"2026-09-18","links":[{"label":"LungenClinic Grosshansdorf","url":"https://www.lungenclinic.de"}],"tags":[],"related":[],"cancers":["lung-cancer","nsclc","pdl1-high-nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":["martin-reck"],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Großhansdorf","country":"DE","lat":53.658,"lng":10.283,"institutionType":"hospital","website":"https://www.lungenclinic.de","programs":["Thoracic oncology","Lung cancer immunotherapy trials","Small-cell lung cancer"]},"route":"/institutions/lungenclinic-grosshansdorf/","neighbours":{"cancer":[{"id":"lung-cancer","kind":"cancer","name":"Lung cancer (all types)","route":"/cancers/lung-cancer/"},{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"},{"id":"pdl1-high-nsclc","kind":"cancer","name":"PD-L1-high non-small-cell lung cancer without a driver mutation","route":"/cancers/pdl1-high-nsclc/"}],"person":[{"id":"martin-reck","kind":"person","name":"Martin Reck","route":"/people/martin-reck/"}]}}